Fog Pharmaceuticals
Creating a new class of medicines that target human disease drivers currently considered “undruggable.”. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
CAD791m—1.2b (Dealroom.co estimates Mar 2024.)
Cambridge Massachusetts (HQ)
Authorizing premium user...